Biotech AbolerIS Pharma Announces First Cohort Dosed in Phase 1 Study of ABO21009, a Novel Anti-CD45RC Antibody, for Rheumatoid Arthritis May 7, 2025
Biotech Gardin Raises $4.5M to Advance Precision Agriculture with Breakthrough Photosynthesis Sensor & AI Platform to Monitor Greenhouse Crop Health at Scale, in Real Time May 7, 2025
Biotech Wobble Genomics Announces Appointment of Dr. Dietrich A. Stephan as Chairman of the Board of Directors May 6, 2025
Biotech IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors May 6, 2025
Biotech IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update May 6, 2025
Biotech IND Application for NTS071, Nutshell Therapeutics’ p53 Y220C Allosteric Reactivator, Received US FDA clearance May 4, 2025
Biotech Pykus Therapeutics Announces Positive Interim Pilot Clinical Trial Results of PYK-2101, a Novel Retinal Sealant May 3, 2025
Biotech Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets May 2, 2025